SKLB-C-05

N/A

Report date: 2022/06/09 17:49:15
NME

Base Information

Drug NameSKLB-C-05
Drug Alias NameSKLB-C-05
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionT LAK cell originated protein kinase inhibitors
TargetsT LAK cell originated protein kinase
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSichuan University
China Registration ClassN/A

Develop Information

Active CompaniesSichuan University
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A